These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37316282)

  • 1. ST-elevation myocardial infarction after thrombolytic therapy with Tenecteplase for acute ischaemic stroke.
    Sinclair JE; Plante M; Harrison MF; Sanghavi DK
    BMJ Case Rep; 2023 Jun; 16(6):. PubMed ID: 37316282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy.
    Inohara T; Liang L; Kosinski AS; Smith EE; Schwamm LH; Hernandez AF; Bhatt DL; Fonarow GC; Peterson ED; Xian Y
    J Am Heart Assoc; 2019 Aug; 8(15):e012450. PubMed ID: 31327296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal treatment modality for coexisting acute myocardial infarction and ischemic stroke.
    Gungoren F; Besli F; Tanriverdi Z; Kocaturk O
    Am J Emerg Med; 2019 Apr; 37(4):795.e1-795.e4. PubMed ID: 30612780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic stroke complicating thrombolytic therapy with tenecteplase for ST elevation myocardial infarction: two case reports.
    Arous S; Haboub M; El Ghali Benouna M; Bentaoune T; Habbal R
    J Med Case Rep; 2017 Jun; 11(1):154. PubMed ID: 28601092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Making a case for the right '-ase' in acute ischemic stroke: alteplase, tenecteplase, and reteplase.
    Chester KW; Corrigan M; Schoeffler JM; Shah M; Toy F; Purdon B; Dillon GM
    Expert Opin Drug Saf; 2019 Feb; 18(2):87-96. PubMed ID: 30712409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenecteplase Thrombolysis for Acute Ischemic Stroke.
    Warach SJ; Dula AN; Milling TJ
    Stroke; 2020 Nov; 51(11):3440-3451. PubMed ID: 33045929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.
    Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW
    Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial.
    Van de Werf F; Ristić AD; Averkov OV; Arias-Mendoza A; Lambert Y; Kerr Saraiva JF; Sepulveda P; Rosell-Ortiz F; French JK; Musić LB; Vandenberghe K; Bogaerts K; Westerhout CM; Pagès A; Danays T; Bainey KR; Sinnaeve P; Goldstein P; Welsh RC; Armstrong PW;
    Circulation; 2023 Aug; 148(9):753-764. PubMed ID: 37439219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dosing errors between tenecteplase and alteplase for management of acute ischemic stroke.
    Ray B; Janzen KM; Curran M; Adamson R; Allen L; Warach S; Daley M
    J Am Pharm Assoc (2003); 2023; 63(2):643-647. PubMed ID: 36623954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ST-elevation myocardial infarction associated with acute ischemic stroke.
    Patanè S; Marte F; Lentini C; Buonamonte S
    Int J Cardiol; 2010 Dec; 145(3):e116-8. PubMed ID: 20110132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retropharyngeal hematoma mimicking angioedema after intravenous thrombolysis for acute ischemic stroke.
    Jolley A; McKnight M; Clark K
    Am J Emerg Med; 2023 May; 67():196.e1-196.e2. PubMed ID: 36948989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
    Menon BK; Buck BH; Singh N; Deschaintre Y; Almekhlafi MA; Coutts SB; Thirunavukkarasu S; Khosravani H; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar J; Williams H; Field TS; Manosalva A; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Demchuk AM; Mishra S; Gioia LC; Jalini S; Cayer C; Phillips S; Elamin E; Shoamanesh A; Subramaniam S; Kate M; Jacquin G; Camden MC; Benali F; Alhabli I; Bala F; Horn M; Stotts G; Hill MD; Gladstone DJ; Poppe A; Sehgal A; Zhang Q; Lethebe BC; Doram C; Ademola A; Shamy M; Kenney C; Sajobi TT; Swartz RH;
    Lancet; 2022 Jul; 400(10347):161-169. PubMed ID: 35779553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenecteplase use in the management of acute ischemic stroke: Literature review and clinical considerations.
    Hailu K; Cannon C; Hayes S
    Am J Health Syst Pharm; 2022 Jun; 79(12):944-949. PubMed ID: 35020806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practice game changer: Impact of tenecteplase for acute ischemic stroke in a multicenter quality improvement project.
    Noh L; Pham F; Haddad L; Burkhard T; Paletz L; Pech M; Lewis M; Manoukian V; Schlick KH; Song S
    Am J Health Syst Pharm; 2022 Apr; 79(9):e149-e153. PubMed ID: 35037028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke.
    Wardlaw JM; Koumellis P; Liu M
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD000514. PubMed ID: 23728633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent stroke and ST-elevation myocardial infarction: Is it a contraindication for intravenous tenecteplase?
    Wan Asyraf WZ; Elengoe S; Che Hassan HH; Abu Bakar A; Remli R
    Med J Malaysia; 2020 Mar; 75(2):169-170. PubMed ID: 32281601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
    Huang X; Cheripelli BK; Lloyd SM; Kalladka D; Moreton FC; Siddiqui A; Ford I; Muir KW
    Lancet Neurol; 2015 Apr; 14(4):368-76. PubMed ID: 25726502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction.
    Melandri G; Vagnarelli F; Calabrese D; Semprini F; Nanni S; Branzi A
    Vasc Health Risk Manag; 2009; 5(1):249-56. PubMed ID: 19436656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke.
    Alamowitch S; Turc G; Palaiodimou L; Bivard A; Cameron A; De Marchis GM; Fromm A; Kõrv J; Roaldsen MB; Katsanos AH; Tsivgoulis G
    Eur Stroke J; 2023 Mar; 8(1):8-54. PubMed ID: 37021186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial.
    Kvistad CE; Næss H; Helleberg BH; Idicula T; Hagberg G; Nordby LM; Jenssen KN; Tobro H; Rörholt DM; Kaur K; Eltoft A; Evensen K; Haasz J; Singaravel G; Fromm A; Thomassen L
    Lancet Neurol; 2022 Jun; 21(6):511-519. PubMed ID: 35525250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.